Variant report
Variant | nsv435907 |
---|---|
Chromosome Location | chr1:104624988-104630301 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548182757 | chr1:104626158-104626159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566686013 | chr1:104626192-104626193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147194622 | chr1:104626197-104626198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558244207 | chr1:104626212-104626213 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539723704 | chr1:104626220-104626221 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185401494 | chr1:104626223-104626224 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11810951 | chr1:104626248-104626249 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs556167040 | chr1:104626260-104626261 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574350011 | chr1:104626290-104626291 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542539330 | chr1:104626304-104626305 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs67847517 | chr1:104626343-104626344 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs187972577 | chr1:104626381-104626382 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138124895 | chr1:104626391-104626392 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546392633 | chr1:104626411-104626412 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568183848 | chr1:104626427-104626428 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564574195 | chr1:104626432-104626433 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531797117 | chr1:104626444-104626445 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200856831 | chr1:104626452-104626453 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532241484 | chr1:104626453-104626454 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201581965 | chr1:104626457-104626458 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566283314 | chr1:104626458-104626459 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75119094 | chr1:104626467-104626468 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74982296 | chr1:104626472-104626473 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9730227 | chr1:104626477-104626478 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200882450 | chr1:104626483-104626484 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529248753 | chr1:104626489-104626490 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548495207 | chr1:104626495-104626496 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28569155 | chr1:104626509-104626510 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs539703470 | chr1:104626519-104626520 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527488575 | chr1:104626526-104626527 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551914918 | chr1:104626527-104626528 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558086536 | chr1:104626535-104626536 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576299354 | chr1:104626558-104626559 | ZNF genes & repeats Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs28457806 | chr1:104626631-104626632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs537994874 | chr1:104626635-104626636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144566895 | chr1:104626658-104626659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568084047 | chr1:104626664-104626665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377642601 | chr1:104626704-104626705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79432635 | chr1:104626715-104626716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113410586 | chr1:104626725-104626726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs80225959 | chr1:104626726-104626727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572730283 | chr1:104626747-104626748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531620524 | chr1:104626783-104626784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2316920 | chr1:104626794-104626795 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs558428995 | chr1:104626805-104626806 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71734805 | chr1:104626819-104626820 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576706742 | chr1:104626826-104626827 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372428701 | chr1:104626827-104626828 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs3056888 | chr1:104626828-104626829 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370160894 | chr1:104626887-104626888 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104626000-104627000 | Enhancers | Fetal Heart | heart |
2 | chr1:104626200-104626600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr1:104626200-104626600 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
4 | chr1:104626600-104627400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr1:104626600-104627600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr1:104626800-104627200 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr1:104626800-104627600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr1:104626800-104627600 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr1:104626800-104627600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr1:104626800-104627600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr1:104626800-104627600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr1:104626800-104627600 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
13 | chr1:104626800-104628400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr1:104626800-104629000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr1:104627400-104627800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr1:104627600-104634600 | Weak transcription | H1 Cell Line | embryonic stem cell |
17 | chr1:104627600-104634600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
18 | chr1:104627800-104628000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr1:104628000-104634600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr1:104628400-104634600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
21 | chr1:104629000-104634600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |